From: Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression
 | Intracellular Pathway | Cell Cycle Effect | References |
---|---|---|---|
GPCR | Â | Â | Â |
G i/o -coupled | Â | Â | Â |
   α1-adrenergic |  | ↑DNA synthesis | [15] |
 | ↑Src/C3G/Rap-1/B-Raf/ERK | ↑Proliferation | [77] |
   Adenosine A3 | ↑PI3K/Akt/↓ERK | ↓Proliferation | [98] |
   CXCR1/2 | ↑MMP/EGFR/ERK | ↑Proliferation | [40] |
   CXCR3 | ↑ERK, ↑p38 | ↑DNA synthesis | [99] |
   CXCR4 | ↑Pyk2/PI3K/ERK | ↑DNA synthesis | [71] |
   Dopamine D2 | ↑PKC/NF-κB | ↑p21Cip1, ↑p27Kip1 | [60] |
 | ↑Src/C3G/Rap-1/B-Raf/ERK | ↑Proliferation | [77] |
   Dopamine D4 | ↑Src/SHC/Ras/ERK | ↑DNA synthesis | [78] |
   Sphingosine 1-phosphate EDG-1 | ↑p70rsk | ↑Cyclin D1 | [96] |
 | ↑PDGFβ/ERK | ↑Proliferation | [100] |
   κ-opioid | ↑PLC/PKC/Ras/ERK | ↑DNA synthesis | [16] |
   Lysophosphatidic acid LPA |  | ↑DNA synthesis | [17] |
   Melatonin MT1 | ↓ERα/glucocorticoid receptor | ↓Cyclin D1 | [12, 13] |
   Serotonin 5HT1E | ↑Src/C3G/Rap-1/B-Raf/ERK | ↑Proliferation | [77] |
   Somatostatin SST1/4/5 | ↑ERK | ↑p21Cip1, ↑p27Kip1 | [50] |
   Somatostatin SST2 | ↑PI3K/Ras/Rap-1/B-Raf/ERK | ↑p27Kip1 | [90] |
   Somatostatin SST2a | ↑p38 | ↑p21Cip1 | [91] |
   Somatostatin SST2b | ↑PI3K/p70rsk/Akt | ↑Proliferation | [91] |
G s -coupled | Â | Â | Â |
   Dopamine D1 | ↑PLCβ/↓Raf-1 | ↓Cyclin D1/↑p27Kip1 | [101] |
   Glucagon-like peptide GLP-1 | EGFR/PI3K | ↑Proliferation | [42] |
   Glucagon-like peptide GLP-2 |  | ↑DNA synthesis | [18] |
   GPR30 | ↑PKA/CREB | ↑Cyclin D2/CDK4-6 complex formation | [27, 28] |
   Lysophosphatidic acid LPA |  | ↑Proliferation | [19] |
   Melanocortin MC5 | ↑JAK/STAT | ↑Proliferation | [82] |
   Parathyroid PTH | ↑cAMP/PKA | ↑p27Kip1 | [7, 22] |
 | ↑cAMP/Epac/Rap-1/B-Raf/ERK | ↑Proliferation | [51] |
 | ↑cAMP/↑PKA/↓Raf-1 | ↓Proliferation | [51] |
 | ↑MKP-1/↓ERK | ↓Cyclin D1, ↑p21Cip1 | [52] |
   Thyroid stimulating hormone TSH | ↑cAMP/CREB/c-Fos | ↑DNA synthesis, ↑Cyclins D1/E | [14, 23-25] |
 | ↑PKA/Ras/PI3K | ↑DNA synthesis | [102] |
G q -coupled | Â | Â | Â |
   α1B-adrenergic | ↑PKC/Raf-1/ERK | ↑Proliferation | [34] |
 | ↑JNK, ↑p38 | ↓Proliferation | [55] |
 | ↑Src/Dbs/cdc42/MKK4/JNK | ↓Proliferation | [76] |
 | ↑Ras/Rac/JAK/STAT | ↑Proliferation | [81] |
   Angiotensin II | ↑MMP/EGFR/ERK | ↑Cyclin D1 | [39] |
 | ↑Ras/ERK/c-Fos/c-Jun | ↑Cyclin D1, ↑pRB phosphorylation | [48] |
 | ↑p125FAK/Rac1/JNK | ↑Proliferation | [67] |
   Bombesin | ↑MMP/EGFR/PI3K | ↑Cyclins D1/E | [41] |
 | ↑PKD | ↑Proliferation | [58] |
   Bradykinin | ↑MMP/EGFR/PI3K | ↑Cyclins D1/E | [41] |
   Endothelin | ↑MMP/EGFR/ERK | ↑DNA synthesis | [39] |
 | ↑PLCβ/Ca2+/Src/ERK | ↑Proliferation | [74] |
 | ↑Src/Rho/p125FAK/paxillin | ↑DNA synthesis | [70] |
 | ↑Pyk2/ERK | ↑DNA synthesis | [70] |
   Gastrin-activated CCK2 | ↑Rho/integrin/p125FAK/paxillin | ↑Proliferation | [68,69] |
 | ↑PKC/Src/p38 | ↑Proliferation | [75] |
 | ↑JAK/STAT | ↑Proliferation | [80] |
   Lysophosphatidic acid LPA | ↑MMP/EGFR/ERK | ↑cyclin D1 | [39] |
   Muscarinic M1 | ↑PKC/Raf-1/ERK | ↑Proliferation | [34] |
   Muscarinic M3 | ↑JNK/c-Jun/SP-1 | ↓DNA synthesis, ↑p21Cip1/CDK2, ↓pRb phosphorylation | [56] |
   Muscarinic M5 | ↑Ras/Rac/JAK/STAT | ↑Proliferation | [81] |
   Muscarinic subtypes | ↑Src/ERK/CREB | ↑DNA synthesis | [103] |
   Platelet-Activating Factor receptor | ↑MMP/EGFR/ERK | ↑Proliferation | [104] |
   Purinergic P2Y2/4 | ↑PKC/Raf/MAPK | ↑DNA synthesis | [49] |
   Substance P (NK-1) | ↑Src/PKCδ/ERK | ↑Proliferation | [72] |
   Thrombin | ↑MMP/EGFR/ERK | ↑DNA synthesis | [39] |
 | ↑RhoA/PI3K/Akt | ↓p27Kip1, ↑Cyclin D1/CDK4 | [92-94] |
 | ↑ERK | ↑CDK2 nuclear translocation | [95] |
 | ↑PI3K/Akt, |  |  |
   Vasopressin V1A | ↑PKD | ↑Proliferation | [58] |
 | ↑Ca2+/PI3K/PKC/ERK | ↑G1-S phase | [105] |
 | ↑EGFR/Pyk2/Src/ERK/PI3K | ↑Proliferation | [106] |
G 12/13 -coupled | Â | Â | Â |
   Lysophosphatidic acid LPA |  | ↑DNA synthesis, ↑Proliferation | [20] |
 | ↑EGFR/Rho/ROCK | ↑Cyclins A/D1, ↑p21Cip1, ↓p27Kip1 | [43,45] |
 | ↑JNK | ↑Cyclin A | [20,54] |